Human genetics of GPR54.
Cerrato. Felecia F; Seminara. Stephanie B SB
Key Findings
- Loss‑of‑function mutations in GPR54 cause idiopathic hypogonadotropic hypogonadism (IHH).
- GPR54 mutations are rare but provide insight into genotype‑phenotype links.
- The kisspeptin‑GPR54 pathway is a key regulator of sexual maturation and hormone release.
Practical Outcomes
- For most biohackers, this research doesn’t change day‑to‑day protocols, but it highlights that the kisspeptin system is crucial for hormone balance. Future therapies might target this pathway to influence reproductive or metabolic health, though no specific dosing guidance is available yet.
Summary
The paper reviews how rare genetic changes in the GPR54 receptor can lead to a condition where puberty doesn’t happen because the body can’t produce the right hormones. While these mutations are uncommon, studying them helps scientists understand how the kisspeptin‑GPR54 system controls reproductive hormones.
Abstract
Idiopathic hypogonadotropic hypogonadism (IHH) is a condition characterized by absence of sexual maturation in the setting of low sex steroids and low/normal gonadotropins. Despite its rarity, considerable genetic heterogeneity and phenotypic variability exists in this disorder. Loss of function mutations in a G protein coupled receptor, GPR54, have been shown to cause IHH. Although mutations in GPR54 are not a common cause of this condition, patients bearing mutations are critical to explore genotype-phenotype correlations and gene function. In this review, we will examine the human genetics studies of GPR54, the phenotypic implications of mutations in this gene, and the emerging roles of the kisspeptin/GPR54 pathway.
Study Information
pubmed
2007
2007-03-03T00:00:00.000Z
10.1007/s11154-007-9027-3
19
60